Poulton Jeffrey V.

EVP, Chief Financial OfficerALNYLAM PHARMACEUTICALS, INC. (ALNY) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$797K
Net Open-Market Flow
-$797K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)114$319.03$36K64K
Mar 4, 2026Sell(S)109$320.01$35K64K
Mar 4, 2026Sell(S)223$325.67$73K62K
Mar 4, 2026Sell(S)818$323.84$265K62K
Mar 4, 2026Sell(S)291$324.88$95K62K
Mar 4, 2026Sell(S)230$320.81$74K64K
Mar 4, 2026Sell(S)309$321.82$99K64K
Mar 4, 2026Sell(S)374$323.01$121K63K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001735276-26-000061) within minutes of acceptance. Every field above traces to the original document. Verify it directly: